Get the content you want anytime you want.
REGISTER NOW | SIGN IN

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HEALTHCARE-ASSOCIATED INFECTIONS (HAI) NEWS - Page 3

IDSA & SHEA Release Updated Clinical Practice Guidelines for <i>Clostridium difficile</i> Infection
Fecal transplantation and molecular testing are among the new recommendations.
ISDD Implementation Leads to Decrease in Blood Culture Contamination
A second hospital finds that the combination of a mechanical initial specimen diversion device (ISDD) and staff education resulted in about a decrease in the contamination of blood cultures.
Top Infectious Disease News of the Week—January 28, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
AVYCAZ Approved to Treat HABP/VABP
The FDA has approved Allergan's sNDA to expand the approved use of AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by certain susceptible Gram-negative microorganisms.
FDA Approves Vancomycin Hydrochloride for Treatment of CDAD & <i>Staphylococcus aureus</i> Enterocolitis
The FDA has approved Firvanq for the treatment of C. diff-associated diarrhea and enterocolitis caused by Staphylococcus aureus.
The C Diff Foundation Raises <i>Clostridium difficile</i> Infection (<i>C. difficile</i>) Clinical Trial Awareness Worldwide
In the USA: Nearly half a million Americans suffer from Clostridium difficile (C. diff.) infections in a single year according to a study released in 2015 by the Centers for Disease Control and Prevention.
Top Infectious Disease News of the Week—January 14, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
SHEA Releases Guidance on Duration of Contact Precautions for MDR Infections
SHEA has released expert guidance advising hospitals on when they can safely take patients with multidrug-resistant bacteria off of contact precautions.